Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
Holly Roberts, Sunjong Ji, Alberto Pïcca, Marc Sanson, Mekka Garcia, Matija Snuderl, Ulrich Schüller, Thiébaud Picart, François Ducray, Adam L. Green, Yoshiko Nakano, Dominik Sturm, Zied Abdullaev, Kenneth Aldape, Derek Dang, Chandan Kumar‐Sinha, Yi‐Mi Wu, Dan R. Robinson, Josh N. Vo, Arul M. Chinnaiyan, Rodrigo T. Cartaxo, Santhosh A. Upadhyaya, Rajen Mody, Jason Chiang, Suzanne J. Baker, David A. Solomon, Sriram Venneti, Drew Pratt, Sebastian M. Waszak, Carl Koschmann
Abstract
International audience
Topics & Concepts
EpigenomicsGliomaMAPK/ERK pathwayPathologyMutantBiologyMedicineOncologyCancer researchInternal medicineGeneticsGeneDNA methylationSignal transductionGene expressionGlioma Diagnosis and TreatmentBrain Metastases and TreatmentCancer, Hypoxia, and Metabolism